Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1136 of 5804
-
New drug combo aims to shield kidneys in type 1 diabetes
Disease control Not yet recruitingThe aim of this study is to test the hypothesis that dapagliflozin (SGLT2 inhibitor) and SC0062 (ERA) combination therapy augments nephroprotection and mitigates fluid retention and ketogenesis in people with T1D through complementary and synergistic mechanisms of actions.
Phase: PHASE2 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New trial aims to spare breast cancer patients from arm swelling
Symptom relief Recruiting nowThis trial is to investigate if in patients with clinically node positive breast cancer undergoing upfront surgery, treatment with TAS and ART is superior to ALND in terms of arm-related Quality of Life (QoL) and occurrence of lymphedema two years after randomization.
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Stomach-Saving surgery could help cancer patients keep weight on
Disease control Not yet recruitingThis clinical trial is evaluating a new, function-preserving surgical technique for patients with early-stage cancer in the upper part of the stomach. The current standard treatment is a Laparoscopic Total Gastrectomy (LTG), which involves the complete removal of the stomach. Th…
Phase: NA • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for nighttime cluster headaches: Low-Sodium drug enters trial
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the efficacy of low sodium oxybate (LXB) (brand name Xywav) in the treatment of (nocturnal) cluster headache attacks in subjects with chronic cluster headache. It is an 16 week, randomized, double-blind, placebo- controlled, bi-cent…
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can sound and light help stroke patients see again?
Symptom relief Not yet recruitingIn this study, the investigators will use a wearable device capable of performing this bedside assessment to evaluate the incidence of visual field loss in post-stroke patients. Furthermore, for those with visual field loss, the investigators will investigate whether integrating …
Phase: NA • Sponsor: Fondazione David Chiossone - Impresa Sociale • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Could a live online heart team save lives in complex heart disease?
Knowledge-focused Not yet recruitingThis is a multi-center randomized controlled trial involving patients with 3-vessel coronary artery disease and diabetes mellitus. Enrolled patients will be dividing into real-time heart team decision-making group (intervention group) and usual care group (control group). The int…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Antibiotic shield may protect young leukemia patients from dangerous infections
Disease control Not yet recruitingThe goal of this clinical trial is To evaluate the benefit of levofloxacin prophylaxis in prolonging the median time to first febrile neutropenia in pediatric ALL patients during induction phase. It will also learn about the safety of levofloxacin during induction treatment. The…
Phase: PHASE4 • Sponsor: Gadjah Mada University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New study pits dronedarone against standard drugs for AF control
Disease control Not yet recruitingThe purpose of this study is to compare two commonly used types of medicine for treating atrial fibrillation (also called AF), a condition that causes an irregular heart rhythm. This study is for adults who have been diagnosed with AF within the past year. Researchers want to fi…
Phase: PHASE4 • Sponsor: Inha University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a common ADHD drug help Parkinson's patients stop freezing in their tracks?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if the medication atomoxetine can reduce freezing of gait in people with Parkinson's disease. The main questions it aims to answer is: Does atomoxetine reduce the frequency or severity of freezing of gait? What role does noradrenaline …
Phase: PHASE3 • Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Fish skin could help burn victims heal with less pain
Disease control ENROLLING_BY_INVITATIONThe goal of this randomized controlled clinical trial is to determine whether use of Kericis Intact Fish Skin Graft (IFSG) can decrease the amount of autograft tissue needed for treatment of deep partial-thickness burns in patients at least 18 years of age with a deep partial-thi…
Phase: PHASE4 • Sponsor: Kerecis Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New trial aims to find best seizure treatment for Oxygen-Deprived newborns
Symptom relief Not yet recruitingAim of the study To evaluate and compare phenobarbital's and levetiracetam's safety and efficacy for treating seizures in neonates with moderate to severe HIE
Phase: PHASE4 • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Radioactive seeds aim to boost tumor control in patients with 6-10 metastases
Disease control Not yet recruitingPatients with more than five and up to ten metastatic lesions often have limited tolerance for surgery, radiotherapy, or thermal ablation because of cumulative treatment burden or expected toxicity. In this setting, systemic therapy alone frequently remains the primary treatment …
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Shorter radiation for breast cancer: 2 weeks vs 3 weeks – which is better?
Disease control Not yet recruitingTo compare the efficacy and safety of two hypofractionated adjuvant radiotherapy regimens 34 Gy in 10 fractions versus 40.05 Gy in 15 fractions in patients with breast cancer treated at the South Egypt Cancer Institute.
Sponsor: Salwa Shawky Bakeet Ali • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New glaucoma surgery showdown: which tiny implant works best?
Disease control Recruiting nowThe goal of this randomized controlled clinical trial is to learn whether two minimally invasive bleb-forming glaucoma implants can effectively treat adult patients with open-angle glaucoma who require surgical lowering of intraocular pressure (IOP). Specifically, the study evalu…
Phase: NA • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for kids with rare kidney disease: telitacicept vs. steroids
Disease control Not yet recruitingTo further evaluate the efficacy and safety of Telitacicept in the treatment of pediatric IgA vasculitis nephritis (IgAVN) within real-world settings, this study employs a multicenter, retrospective and prospective observational research design. It aims to compare the efficacy of…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New CAR-T therapy targets lymphoma that escapes standard treatment
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and tolerability of BAFF-R CAR-T Cells in Adult Subjects with CD19-Negative relapsed or refractory B-Cell Lymphoma.
Phase: PHASE1 • Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Hope for rhabdomyosarcoma: vitamin a derivative joins chemo in new trial
Disease control Not yet recruitingThis study is a prospective, multi-cohort, multi-center clinical trial targeting patients with intermediate-to-high-risk rhabdomyosarcoma who have not previously received systemic anti-tumor treatment. It aims to evaluate the efficacy and safety of all-trans retinoic acid combine…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
AI could predict when prostate cancer becomes resistant to treatment
Diagnosis Not yet recruitingThe goal of this predictive test is to prospectively test the performance of pre-developed artificial intelligence (AI) predictive model for predicting the time to castration resistance of prostate cancer. Investigators had developed this AI model based on deep learning algorithm…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Breast cancer trial aims to spare women unnecessary surgery
Disease control OngoingThe neoadjuvant system therapy (NAST) can significantly increase the pathological complete response (pCR) rate for patients with triple-negative (TNBC) and HER2-positive breast cancer. Some patients can achieve complete disappearance of the tumor or only residual tumors ≤ 2 cm in…
Phase: NA • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can AI help doctors spot diseases faster and better?
Diagnosis Recruiting nowThis study aims to evaluate the diagnostic performance and clinical utility of a multimodal medical imaging large model in identifying common systemic diseases. Through a retrospective reader study involving multiple centers, the research will compare the diagnostic accuracy, sen…
Sponsor: The Third Affiliated Hospital of Southern Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC